PCM
PSTX

Prelude Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Prelude Capital Management’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,250
Closed -$50K – 1889
2022
Q1 		$50K Buy
+11,250
New +$50K ﹤0.01% 1193